학술논문
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Document Type
Article
Author
Lee, Chung-Han ; Shah, Amishi Yogesh; Rasco, Drew; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Shaffer, David R; Girones Sarrio, Regina; Cohn, Allen Lee; Vogelzang, Nicholas J; Bilen, Mehmet Asim; Gunnestad Ribe, Sara; Goksel, Musaberk; Tennøe, Øyvind Krohn; Richards, Donald; Sweis, Randy F; Courtright, Jay; Heinrich, Daniel; Jain, Sharad; Wu, Jane; Schmidt, Emmett V; Perini, Rodolfo F; Kubiak, Peter; Okpara, Chinyere E; Smith, Alan D; Motzer, Robert J
Source
In The Lancet Oncology July 2021 22(7):946-958
Subject
Language
ISSN
1470-2045